Full Breakdown
NHS to Roll Out Newborn Screening for Spinal Muscular Atrophy
4/2/2026, 11:02:17 PM
Announcement of Early Screening Rollout
The UK government has announced that screening for spinal muscular atrophy (SMA) will commence in October 2026, a significant advancement from the previously scheduled January 2027 start date. Health Secretary Wes Streeting confirmed this decision in a letter to Jesy Nelson, a former member of the band Little Mix, and Giles Lomax, chief executive of the charity SMA UK. This initiative aims to screen over 400,000 newborns in England for SMA, a rare genetic condition that leads to progressive muscle wasting.
Background and Advocacy
Jesy Nelson has been a vocal advocate for SMA screening following the diagnosis of her twin daughters, Ocean Jade and Story Monroe, who were born with the condition. Nelson's campaign has highlighted the devastating impact of late diagnosis, which in her daughters' case resulted in irreversible nerve damage. In her advocacy, she has emphasized the importance of early detection, stating, “I just wish this had been here for my babies and for all the SMA babies who never got tested.”
Official Statements and Responses
Wes Streeting expressed his appreciation for Nelson's efforts, stating, “It was great to meet you both. I really appreciated you sharing your personal experiences of raising children with SMA and applaud the work you have both done highlighting the issue and seeking earlier diagnosis.” Lomax also celebrated the announcement, noting that it would change the lives of many families affected by SMA.
Criticism and Concerns
Despite the positive developments, concerns remain regarding the rollout. The pilot program will leave approximately 163,000 newborns untested to serve as a control group, a decision that has been criticized as “unethical” by experts. Jesy Nelson remarked on this issue, stating, “It’s just bittersweet because we’re not fully there yet. It’s like literally a postcode lottery because it’s not the whole of England.”
Broader Implications
The UK has lagged behind other countries in implementing SMA screening, with 45 nations already conducting such tests. The National Screening Committee had previously declined to include SMA in the newborn screening program since 2018, citing the need for further studies. However, with advancements in treatment options, including gene therapies that can effectively halt the progression of the disease if administered early, the urgency for screening has intensified.
What's Next
The pilot program will begin in October 2026, and officials are working to address challenges related to extending the screening to all of England. The devolved government in Scotland has already committed to screening all newborns for SMA, while no similar decisions have been made for Wales and Northern Ireland.
Verbatim Quotes
- “This is massive. Now there are potentially 404,000 babies who will be screened over the next 12 months. I just wish this had been here for my babies and for all the SMA babies who never got tested. That’s why I wanted to do this - I don’t want anyone to have to go through this heartbreak.” — Jesy Nelson
- “In a statement shared on the charity website, Mr Lomax added: “Following years of campaigning, we are delighted to see the formal announcement that screening for SMA will start in six months’ time in England.” — Giles Lomax, Chief Executive of SMA UK
- “We will continue to work hard to ensure this SMA is rolled out to other parts of England as well as the home nations, no baby should be left behind based on where they live.” — Giles Lomax
This initiative represents a crucial step forward in addressing SMA, with hopes that it will lead to earlier diagnoses and improved outcomes for affected infants.
